Drug Giants Get Mixed Reviews for Products in the UK, Germany

International Pharmaceutical Regulatory Monitor
A A
Johnson & Johnson and Novartis each scored a victory in the UK, with the National Institute for Health and Care Excellence backing their respective treatments for prostate cancer and heart failure.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor